Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility-weighted imaging at 3.0 Tesla.
about
Multiple sclerosis: molecular mechanisms and therapeutic opportunitiesCerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis?Sensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosisWhat went wrong? The flawed concept of cerebrospinal venous insufficiency.Magnetic resonance imaging signatures of vascular pathology in multiple sclerosis.Susceptibility-weighted imaging: current status and future directions.Cerebral Hemodynamics in Patients with Hemolytic Uremic Syndrome Assessed by Susceptibility Weighted Imaging and Four-Dimensional Non-Contrast MR AngiographyImaging the effects of oxygen saturation changes in voluntary apnea and hyperventilation on susceptibility-weighted imagingX-Ray Phase Contrast Tomography Reveals Early Vascular Alterations and Neuronal Loss in a Multiple Sclerosis Model.Energy failure in multiple sclerosis and its investigation using MR techniques.Pathogenic implications of iron accumulation in multiple sclerosis.Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency.Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosisVenous hemodynamics in neurological disorders: an analytical review with hydrodynamic analysisQuantitative oxygen extraction fraction from 7-Tesla MRI phase: reproducibility and application in multiple sclerosisSemiautomated detection of cerebral microbleeds in magnetic resonance images.Aspirin and multiple sclerosisMagnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration.Characterizing brain oxygen metabolism in patients with multiple sclerosis with T2-relaxation-under-spin-tagging MRI.Perivenular brain lesions in a primate multiple sclerosis model at 7-tesla magnetic resonance imagingMultiple sclerosis shrinks intralesional, and enlarges extralesional, brain parenchymal veins.Widespread inflammation in CLIPPERS syndrome indicated by autopsy and ultra-high-field 7T MRICharacterization of microcirculation in multiple sclerosis lesions by dynamic texture parameter analysis (DTPA)Quantification of deep medullary veins at 7 T brain MRI.Cerebrospinal fluid flow dynamics in patients with multiple sclerosis: a phase contrast magnetic resonance study.Chronic cerebrospinal venous insufficiency in multiple sclerosis: diagnostic, pathogenetic, clinical and treatment perspectives.Veins in plaques of multiple sclerosis patients - a longitudinal magnetic resonance imaging study at 7 Tesla.Advanced magnetic resonance imaging techniques to better understand multiple sclerosis.A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field.Group specific vein-atlasing: an application for analyzing the venous system under normal and multiple sclerosis conditions.Periventricular venous density in multiple sclerosis is inversely associated with T2 lesion count: a 7 Tesla MRI study.Diffusion-weighted imaging thermometry in multiple sclerosis.Spatiotemporal evolution of venous narrowing in acute MS lesions.Presence of a central vein within white matter lesions on susceptibility weighted imaging: a specific finding for multiple sclerosis?The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis?Regional Frontal Perfusion Deficits in Relapsing-Remitting Multiple Sclerosis with Cognitive Decline.Decreased frontal lobe gray matter perfusion in cognitively impaired patients with secondary-progressive multiple sclerosis detected by the bookend technique.Focal hemodynamic patterns of status epilepticus detected by susceptibility weighted imaging (SWI).Iron deposition in multiple sclerosis lesions measured by susceptibility-weighted imaging filtered phase: a case control study.Neuromyelitis optica does not impact periventricular venous density versus healthy controls: a 7.0 Tesla MRI clinical study.
P2860
Q27023735-679376E8-B82F-4711-A941-38AE78503D9EQ27027921-96D1B533-5AFD-4A52-A482-A2E2F1E4D2A5Q28269079-3102FEB4-BAAF-4C63-A10F-A41C55FA504BQ30454634-D9B633D0-C6BD-4292-91F3-1DFAF1291152Q30564477-3661C266-08A8-4A8F-95AD-272BF6D04662Q31097031-83F78A2A-9168-47B1-BA2B-99E58DEE4D05Q33436459-03BF4339-28DD-4E3F-A263-2D2C9DA6016CQ33753999-919EFCAC-43A0-403C-B7DE-6E34A9D936E9Q33919133-F861773E-008C-42A2-B024-DB85D402AFADQ33928808-214ADE83-5991-4320-BD7A-E58D7918C8D3Q34049616-8AA2C12D-2510-4528-9F80-BB26C2DB6A09Q34051741-FEBB1EC2-1893-468D-8EE0-CBFA6D2230DFQ34203136-0EADBA68-62E4-47FA-9B57-E2F095F7FBEDQ34750423-45B444A3-A49E-4A10-B086-C90A6BB96918Q34957622-FCFC15E1-6AF0-445F-BE89-D60867F03D51Q35056321-9628DA26-EFA0-4B59-AFA3-2D2C96A4B71DQ35678040-E14A3E6F-6E12-4BD7-92EF-33B6FB96663AQ35694584-DDC52E6C-6CCF-471A-86DD-B2E7463D9DD6Q35800537-6AC8E74A-88BB-4AD1-8D28-C8A9033208F5Q36557924-AB6F1554-692D-411B-9A16-E02D228CD8A2Q36659375-1F979659-451D-49E8-942B-39AFCF829E0FQ36827200-54831AA5-6AF3-4D6D-9E96-40B1CCF7FE74Q37017890-B198C509-CDD9-4371-96DA-F659F0AEAF75Q37253613-B6D37B9E-3AD2-4C47-99DF-93BEC2F5E802Q37271604-DEC9B54D-7366-41B1-83CB-676071AA5059Q37921764-3B0E743A-6423-46AA-BADD-A1527F5558D6Q41027045-B44BAED8-5478-4C02-AFF8-BB0AE9ABAD35Q41997313-C0DF7EEC-AE8A-441C-8BD2-8C5D91217383Q42573864-41EDC755-5C2F-4EFF-BA76-A2C13AFE5615Q43491444-542A76D1-EDEF-48B6-A254-7FA829F22D24Q44208203-BB159E17-9F04-4538-88E1-2458594F2E7BQ46507006-6C5EE54A-2890-43BC-BDCF-7AD638B1F7A1Q47845780-D66C0703-6483-497E-80BF-132317A12356Q48149000-91535D0A-0D8D-40AF-8673-4A0C88DC6BE2Q48151106-9F91BF01-5CB7-446D-9F8C-47C9E74BA00BQ48228805-FE03252C-7955-46C2-8E3C-95C50A12F6D1Q48546484-FED92A2D-08C3-487A-AEBE-A3678F715344Q48619251-803BD2FA-089F-4D7A-BB9F-7476A4F12E77Q48619811-7B5B3B3D-2C2A-4C4A-B2C7-2EDA6B4163BDQ48746749-3806C477-928C-48AC-BBBB-5CF6ABEE90ED
P2860
Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility-weighted imaging at 3.0 Tesla.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Diminished visibility of cereb ...... weighted imaging at 3.0 Tesla.
@ast
Diminished visibility of cereb ...... weighted imaging at 3.0 Tesla.
@en
type
label
Diminished visibility of cereb ...... weighted imaging at 3.0 Tesla.
@ast
Diminished visibility of cereb ...... weighted imaging at 3.0 Tesla.
@en
prefLabel
Diminished visibility of cereb ...... weighted imaging at 3.0 Tesla.
@ast
Diminished visibility of cereb ...... weighted imaging at 3.0 Tesla.
@en
P2093
P2860
P356
P1476
Diminished visibility of cereb ...... -weighted imaging at 3.0 Tesla
@en
P2093
E Mark Haacke
Etin-Osa Osa
Hina Jaggi
Joseph Herbert
Robert I Grossman
Vahe M Zohrabian
P2860
P304
P356
10.1002/JMRI.21758
P50
P577
2009-05-01T00:00:00Z